Skip to main content
Premium Trial:

Request an Annual Quote

Beverly Lyman, Patrick Kelly, Marc Segal, Sam Fiorello

Thompson Hine LLP has added an intellectual property practice to its Atlanta office and named Beverly Lyman, a partner in the firm's Intellectual Property and Life Sciences practice groups, as head.
Lyman focuses her practice on chemical, medical, and life sciences patent evaluation, enforcement, transactions and prosecution; as well as on trademark, trade secret, and copyright matters. She is a registered patent attorney and a former faculty member at the medical campus of the University of Tennessee. Lyman is an adjunct professor at the University of Cincinnati College of Law. She also lectures on biotechnology patent prosecution for the Patent Resources Group.

Ballard Spahr Andrews & Ingersoll LLP last week announced that Patrick Kelly has joined the firm as a partner in the intellectual property department and a member of the life sciences/technology and the biotechnology patent practices.
Kelly holds several advanced degrees including a PhD from the Georgia Institute of Technology. His background includes working as on-site intellectual property counsel to pharmaceutical and scientific instrumentation companies; conducting validity, due diligence, and freedom-to-operate studies; maintaining a biotech IP estate; and preparing and prosecuting patent applications related to molecular biology. He also has knowledge of biochemistry, immunology, drug delivery systems, and the preparation of proteins by recombinant DNA methods among other areas, Ballard Spahr said.
Ballard Spahr also announced that Marc Segal has joined the firm’s intellectual property department. Segal will be a member of the intellectual property litigation, biotechnology patent, and pharmaceutical patent practices.
Kelly and Segal will be based in Philadelphia and complement the recently added Needle & Rosenberg intellectual property practice of Ballard Spahr in Atlanta, the firm said.

Sam Fiorello has been appointed the first president of the Bio-Research & Development Growth Park, a new biocampus scheduled to open in April 2009 at the Danforth Plant Science Center in the St. Louis suburb of Creve Coeur, Mo.
Fiorello will also continue to serve as the Danforth center’s chief operating officer and senior vice president for administration and finance.
Fiorello joined the Danforth center nine years ago. Previously, he was chief of staff at Monsanto Company's office of the president. Earlier, Fiorello was a senior trade and investment policy analyst with Walker/Free Associates in Washington, DC. His career also includes having worked at Cargill Investor Services and for Confindustria, an Italian industrial policy research center.
Fiorello holds a graduate degree in public administration from the University of Texas, and a BBA degree from the University of Wisconsin.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.